Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideREGNRegeneron Pharmaceuticals
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | REGN | TMO |
|---|
| Close | 789.45 | 658.32 |
| Market Cap | $79.7B | $240B |
| 1M | −2.57% | +11.76% |
| P/E (TTM) | 18.5 | 34.4 |
| Forward P/E | 14.1 | 21.8 |
| P/E 5-Yr Percentile | 48 | 65 |
| P/S | 5.2 | 5.2 |
| P/B | 2.5 | 4.6 |
| Dividend Yield | 0.47% | 0.29% |
| Latest Quarter Revenue | $4.3B | $12.0B |
| Revenue YoY | +16.7% | +10.5% |
| Gross Margin | — | — |
| Latest Quarter EPS | 12.23 | 4.68 |
| Avg Post-Earnings Move | ±1.7% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 4.61% | 2.36% |
| 90-Day Net Insider Buying | −$3.4M | −$38.9M |
REGN · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
